Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-1132P** (RNA, U6 small nuclear 1132, pseudogene) is a human gene classified as a pseudogene of the U6 small nuclear RNA family[4]. Pseudogenes are typically non-functional genomic DNA sequences similar to normal genes but are unable to encode functional products. U6 snRNA itself is a highly conserved and essential component of the major spliceosome complex, catalyzing the excision of introns from pre-mRNA in the nucleus of eukaryotic cells[1][3]. However, pseudogenes such as RNU6-1132P are generally not transcribed into functional RNA and do not participate in biological processes like splicing, nor do they serve as therapeutic targets or interact directly with drugs[4][5]. **RNU6-1132P** is not a known therapeutic target, disease biomarker, or locus of drug interaction. Its primary relevance is genomic annotation rather than any direct functional or clinical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1132, pseudogene (RNU6-1132P).